Lumida
/NGNE
⌘K
Neurogene Inc

Neurogene Inc

NGNE
$37.31USD+2.22%+0.81 today

MARKET CAP

743.5M

P/E (TTM)

FWD P/E

DAY RANGE

$35 – $38

52W RANGE

$16
$44

AI Summary

Stalk
Buy NowMedium

The stock maintains a bullish medium- and long-term structure, anchored by rising major moving averages and a sequence of higher lows. A recent pullback into the 9/21 EMA support zone was absorbed, signaling acceptance and a favorable entry bias. RSI holds in neutral territory, avoiding overbought extremes. Execution is recommended now, buying into minor pullbacks toward the EMA support area.

  • Consensus price target $84.83 implies 121% upside from $39.63.
  • Phase 3 EMBOLDEN trial dosing success strengthens FDA approval path.
  • Earnings yield deeply negative and profitability weak, risking cash burn.
Full analysis →
Insider Trades13 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 6, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,800$36.12$743.5M-14.54%+134.21%$173.4K-2.71%10b5-1Buy Now
Jul 1, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,800$34.71$743.5M-14.54%+134.21%$166.6K-1.73%10b5-1Buy Now
May 6, 2026SellNGNEChristine Mikail CvijicPresident and CFO9,600$31.25$743.5M-14.54%+134.21%$300.0K-4.76%10b5-1Buy Now
Mar 26, 2026SellNGNEJulie JordanChief Medical Officer828$21.89$743.5M-14.54%+134.21%$18.1K-6.23%Buy Now
Mar 26, 2026SellNGNEChristine Mikail CvijicPresident and CFO2,558$21.62$743.5M-14.54%+134.21%$55.3K-2.42%Buy Now
Mar 26, 2026SellNGNERachel McminnChief Executive Officer3,352$22.07$743.5M-14.54%+134.21%$74.0K-0.25%Buy Now
Mar 13, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,045$20.81$743.5M-14.54%+134.21%$84.2K-1.25%Buy Now
Mar 13, 2026SellNGNEStuart CobbChief Scientific Officer6,797$20.81$743.5M-14.54%+134.21%$141.4K-6.71%10b5-1Buy Now
Feb 27, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,800$25.11$743.5M-14.54%+134.21%$120.5K-4.19%10b5-1Buy Now
May 14, 2025SellNGNEStuart CobbChief Scientific Officer6,797$15.15$743.5M-14.54%+134.21%$103.0K-24.63%10b5-1Buy Now
Mar 13, 2025SellNGNEChristine Mikail CvijicPresident and CFO4,501$16.94$743.5M-14.54%+134.21%$76.2K-5.86%Buy Now
Nov 22, 2024BuyNGNEChristine Mikail CvijicPresident and CFO24,000$20.48$743.5M-14.54%+134.21%$491.4K+45.42%Buy Now
Nov 22, 2024BuyNGNERachel McminnChief Executive Officer47,500$20.40$743.5M-14.54%+134.21%$969.0K+3.80%Buy Now